Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebo

ClinicalTrials.gov ID: NCT04221230

Public ClinicalTrials.gov record NCT04221230. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 8:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Randomized, Double-blind, Placebo-controlled Proof of Concept Study to Evaluate the Effects of Oral BTRX-335140 (NMRA-335140) Versus Placebo in Subjects With Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A proof of concept (POC) study evaluating the impact of NMRA-335140 (BTRX-335140) relative to placebo on symptoms of major depressive disorder (MDD) in adult participants with MDD and symptoms of anhedonia and anxiety following 8 weeks of double-blind treatment as assessed by the HAMD-17 Scale.

Study identification

NCT ID
NCT04221230
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Neumora Therapeutics, Inc.
Industry
Enrollment
204 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 3, 2020 (Actual)
Primary completion
Apr 8, 2022 (Actual)
Completion
Jun 23, 2022 (Actual)
Last update posted
May 29, 2025

2020 – 2022

United States locations

U.S. sites
38
U.S. states
13
U.S. cities
35
Facility City State ZIP Site status
Neumora Investigator Site Phoenix Arizona 85016 —
Neumora Investigator Site Bentonville Arkansas 72712 —
Neumora Investigator Site Little Rock Arkansas 72211 —
Neumora Investigator Site Bellflower California 90706 —
Neumora Investigator Site Culver City California 90230 —
Neumora Investigator Site Garden Grove California 92845 —
Neumora Investigator Site Glendale California 91206 —
Neumora Investigator Site Long Beach California 90807 —
Neumora Investigator Site Oakland California 94607 —
Neumora Investigator Site Riverside California 92506 —
Neumora Investigator Site San Jose California 95124 —
Neumora Investigator Site Santa Ana California 92705 —
Neumora Investigator Site Sherman Oaks California 91403 —
Neumora Investigator Site Torrance California 90502 —
Neumora Investigator Site Upland California 91786 —
Neumora Investigator Site Fernandina Beach Florida 32034 —
Neumora Investigator Site Jacksonville Florida 32256 —
Neumora Investigator Site Lauderhill Florida 33319 —
Neumora Investigator Site Miami Lakes Florida 33016 —
Neumora Investigator Site Orlando Florida 32751 —
Neumora Investigator Site Orlando Florida 32801 —
Neumora Investigator Site Sarasota Florida 34243 —
Neumora Investigator Site Atlanta Georgia 30328 —
Neumora Investigator Site Atlanta Georgia 30331 —
Neumora Investigator Site Atlanta Georgia 30338 —
Neumora Investigator Site Decatur Georgia 30030 —
Neumora Investigator Site Las Vegas Nevada 89102 —
Neumora Investigator Site Berlin New Jersey 08009 —
Neumora Investigator Site Brooklyn New York 11229 —
Neumora Investigator Site Jamaica New York 11432 —
Neumora Investigator Site New York New York 10036 —
Neumora Investigator Site Rochester New York 14618 —
Neumora Investigator Site Staten Island New York 10312 —
Neumora Investigator Site Dayton Ohio 45417 —
Neumora Investigator Site Oklahoma City Oklahoma 73112 —
Neumora Investigator Site Memphis Tennessee 38119 —
Neumora Investigator Site Wichita Falls Texas 76309 —
Neumora Investigator Site Clinton Utah 84015 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04221230, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 29, 2025 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04221230 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →